Loratadin-Mepha, Tabletten - 28 Swissmedic Key 57209003 Registration Holder Mepha Pharma AG Name Loratadin-Mepha, Tabletten Date of registration 12.01.2006 Introduction of Sequence 12.01.2006 ATC-Classification Loratadine (R06AX13) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.13.10. Show package size 28 Index Therapeuticus (Swissmedic) 07.13.10. Description Swissmedic categorie. D SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680572090031 Medication Code Synthetika Pharmacode 3160649 Disponibility
Composition loratadinum 10 mg, lactosum monohydricum 75 mg, cellulosum microcristallinum, maydis amylum, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Loratadine 10 mg
BAG: Active Agent Dose Loratadine 10 mg
Inactive agents Dose Cellulosum Microcristallinum Lactose Monohydrate 75 mg Magnesii Stearas Maydis Amylum Pro Compresso
Source Data was imported : 04.10.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :